BioCentury | Dec 10, 2020
Deals

Late in a year of cancer deals, Gilead spends $1B+ to add an antiviral for HDV

...$21 billion purchase of Immunomedics Inc. in September, Gilead’s largest M&A deal ever.MYR’s investors included Maxwell Biotech Venture Fund...
BioCentury | Apr 21, 2017
Clinical News

SQ109: Ph IIb/III data

...Russia and the Commonwealth of Independent States under a 2011 deal between Russian financial firm Maxwell Biotech Venture Fund...
BioCentury | Aug 11, 2014
Clinical News

MM-D37K: Phase I/IIa started

...with advanced solid malignancies, including glioblastoma and gastrointestinal tumors. MetaMax is a portfolio company of Maxwell Biotech Venture Fund...
BioCentury | Oct 8, 2012
Financial News

Eleventa completes venture financing

...Moscow, Russia Business: Inflammation Date completed: 10/4/12 Type: Venture financing Raised: Not disclosed Investor: Maxwell Biotech Venture Fund WIR...
BioCentury | Oct 5, 2012
Financial News

Russian newco Eleventa debuts with Maxwell investment

Maxwell Biotech Venture Fund said it made an undisclosed investment in Russian newco Eleventa. Eleventa is partnered with Oxagen Ltd. (Abingdon, U.K.) to develop asthma therapy OC459, a prostaglandin D2 (PGD2) receptor subtype DP2 (PTGDR2)...
BioCentury | Oct 1, 2012
Financial News

Osteros Biomedica completes venture financing

...Ltd. , Russia Business: Cancer Date completed: 9/24/12 Type: Venture financing Raised: Not disclosed Investor: Maxwell Biotech Venture Fund WIR...
BioCentury | Oct 1, 2012
Company News

MBC Pharma, Osteros Biomedica deal

...late next year. Osteros did not disclose details. Separately, Osteros raised an undisclosed amount from Maxwell Biotech Venture Fund...
BioCentury | Mar 26, 2012
Financial News

Hepatera completes venture financing

...Moscow, Russia Business: Infectious Date completed: 3/20/12 Type: Venture financing Raised: Not disclosed Investors: Maxwell Biotech Venture Fund...
BioCentury | Mar 26, 2012
Financial News

MYR completes venture financing

...Burgwedel, Germany Business: Infectious Date completed: 3/20/12 Type: Venture financing Raised: Not disclosed Investors: Maxwell Biotech Venture Fund...
BioCentury | Mar 23, 2012
Financial News

Hepatera, MYR close series A round

...in series A rounds from an investment partnership of High-Tech Gruenderfonds and Russian government backed Maxwell Biotech Venture Fund...
Items per page:
1 - 10 of 11
BioCentury | Dec 10, 2020
Deals

Late in a year of cancer deals, Gilead spends $1B+ to add an antiviral for HDV

...$21 billion purchase of Immunomedics Inc. in September, Gilead’s largest M&A deal ever.MYR’s investors included Maxwell Biotech Venture Fund...
BioCentury | Apr 21, 2017
Clinical News

SQ109: Ph IIb/III data

...Russia and the Commonwealth of Independent States under a 2011 deal between Russian financial firm Maxwell Biotech Venture Fund...
BioCentury | Aug 11, 2014
Clinical News

MM-D37K: Phase I/IIa started

...with advanced solid malignancies, including glioblastoma and gastrointestinal tumors. MetaMax is a portfolio company of Maxwell Biotech Venture Fund...
BioCentury | Oct 8, 2012
Financial News

Eleventa completes venture financing

...Moscow, Russia Business: Inflammation Date completed: 10/4/12 Type: Venture financing Raised: Not disclosed Investor: Maxwell Biotech Venture Fund WIR...
BioCentury | Oct 5, 2012
Financial News

Russian newco Eleventa debuts with Maxwell investment

Maxwell Biotech Venture Fund said it made an undisclosed investment in Russian newco Eleventa. Eleventa is partnered with Oxagen Ltd. (Abingdon, U.K.) to develop asthma therapy OC459, a prostaglandin D2 (PGD2) receptor subtype DP2 (PTGDR2)...
BioCentury | Oct 1, 2012
Financial News

Osteros Biomedica completes venture financing

...Ltd. , Russia Business: Cancer Date completed: 9/24/12 Type: Venture financing Raised: Not disclosed Investor: Maxwell Biotech Venture Fund WIR...
BioCentury | Oct 1, 2012
Company News

MBC Pharma, Osteros Biomedica deal

...late next year. Osteros did not disclose details. Separately, Osteros raised an undisclosed amount from Maxwell Biotech Venture Fund...
BioCentury | Mar 26, 2012
Financial News

Hepatera completes venture financing

...Moscow, Russia Business: Infectious Date completed: 3/20/12 Type: Venture financing Raised: Not disclosed Investors: Maxwell Biotech Venture Fund...
BioCentury | Mar 26, 2012
Financial News

MYR completes venture financing

...Burgwedel, Germany Business: Infectious Date completed: 3/20/12 Type: Venture financing Raised: Not disclosed Investors: Maxwell Biotech Venture Fund...
BioCentury | Mar 23, 2012
Financial News

Hepatera, MYR close series A round

...in series A rounds from an investment partnership of High-Tech Gruenderfonds and Russian government backed Maxwell Biotech Venture Fund...
Items per page:
1 - 10 of 11